BU Spinout AllegroDx to Launch Array-Based Lung Cancer Test This Year

The Boston-based molecular diagnostics firm intends to offer the test, called BronchoGen, as a service through its CLIA lab by the end of 2010. The firm is also mulling submitting the test, which is manufactured by Affymetrix, to the US Food and Drug Administration for clearance.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.